A small fraction of the CBD in an ointment does reach your bloodstream, but far less than from swallowing or inhaling it. Topical cannabidiol penetrates the skin barrier slowly, and the amount depends on the formulation's chemistry. Most commercial CBD ointments deliver a tiny, measurable dose into circulation rather than large systemic levels. Whether that trickle matters depends on what you expect it to do. For localized joint or muscle discomfort, meaningful blood levels may not be the goal at all.
How skin blocks and passes CBD
Skin is a layered barrier built to keep foreign molecules out. The outer stratum corneum packs dead, keratinized cells into a lipid matrix that behaves like a brick wall. Any CBD molecule entering the bloodstream enters through that wall. Your skin offers three routes. One is the tortuous path between cells through the lipid mortar. Another is through the cells themselves. The third, and most important for systemic absorption, is through hair follicles and sweat ducts, which open directly into the dermis where capillaries lie.
Lipophilic compounds like CBD tend to cross through the lipid mortar between cells. CBD dissolves readily in fats and poorly in water, and that means a proper ointment base can enhance its skin penetration. An anhydrous salve, meaning one without water, keeps CBD dissolved in oils and waxes that disrupt the packed lipids. The tighter and more occlusive the base, the more it softens that outer barrier. A light lotion does far less.
The epidermis below the stratum corneum is the real gatekeeper for systemic delivery. Even after a molecule crosses the outer wall, it must traverse living skin layers to reach dermal capillaries. The skin also acts as a reservoir, holding lipophilic compounds in the outer layers and leaking them slowly. This means a topical application can keep trickling small amounts into blood for hours after you apply it.
Quantified comparison of routes
Precise blood levels from ointments are hard to cite because transdermal CBD products vary enormously in base, concentration, and studied formulations. What is well documented is how the standard routes compare in bioavailability, roughly how much of a dose actually reaches circulation.
| Route | Rough bioavailability | Typical onset to blood | Notes |
|---|---|---|---|
| Intravenous | Near complete | Minutes | Reference standard; not a consumer route |
| Inhaled vapor | Moderate, variable | Seconds to minutes | Depends on device and inhalation |
| Oral swallowed | Low, variable | 1 to 3 hours | First-pass liver metabolism reduces the dose |
| Oral mucosal (under tongue) | Higher than swallowed | 15 to 60 minutes | Partly avoids liver breakdown |
| Topical ointment, intact skin | Very low | Hours | Most stays in the skin or is lost to the surface |
| Topical on broken or inflamed skin | Low but elevated | Hours | Barrier damage raises absorption |
The numbers are approximate ranges drawn from route-comparison reviews, because studies on different subjects and products are not directly interchangeable. One professional caveat applies to that table: skin absorption can be boosted by order of magnitude with penetration enhancers or occlusion wraps. A greasy salve covered with plastic film behaves less like a typical cosmetic and more like a dose delivery system. Never treat any ointment as having fully predictable systemic absorption.
The plain version: hard, intact skin is designed to keep things out, so an ointment's blood levels sit near the bottom of that table unless the product is clearly engineered to cross it.
Timeline of what happens after you rub it on
With most routes, the timeline below describes the general pattern reviewers report. Specific figures depend on the product, so these are typical shapes rather than guaranteed thresholds.
| Time after application | What is happening |
|---|---|
| 0 to 15 minutes | CBD absorbs into the outer skin layers; surface film remains |
| 15 to 60 minutes | Some CBD reaches deeper skin; nearby capillaries begin slow uptake |
| 1 to 3 hours | Blood levels rise slowly; skin reservoir still releasing CBD |
| 3 to 8 hours | Levels reach their slow peak or a plateau |
| 8 to 12 hours | Gradual decline as the reservoir empties |
| 12 to 24 hours | Little additional absorption from that dose |
Compare this with swallowing a CBD capsule, where peak blood concentrations commonly appear within 1 to 3 hours and decline across 8 to 12 hours. Ointment kinetics are slower mainly because transport through skin is the rate-limiting step. CBD itself is eliminated from the body over several days, but the slow skin release dominates the early curve.
One counterintuitive detail: "topical" on a label does not mean "only acts locally." Even low systemic absorption is still absorption. If you are monitoring a drug test, or coordinating with prescription medication, a transdermal product can contribute a small but nonzero amount.
Where the thin explainers get it wrong
A common claim is that CBD ointments are strictly local and never reach blood. That is false at small scale. The truthful statement is that low systemic levels are typical, not that zero absorption occurs. The skin does not offer a perfect seal.
Another error: treating all topical products the same. Lotions, salves, gels, patches, and occlusion wraps sit on a wide absorption spectrum. A patch designed for continuous transdermal delivery can push meaningful blood levels; a thin cosmetic lotion mostly stays superficial. Product category matters more than the CBD concentration number printed on the jar.
Some reviews blur hemp-derived cosmetics with transdermal patches. These are regulated differently and studied differently. Treating them as interchangeable produces the impression that all topical CBD is either useless or intoxicating, when neither is uniformly true.
The edge cases that change everything are broken skin, heat, and occlusion. Shaved, scratched, or sunburned skin loses barrier function and lets more CBD through. Sauna heat and exercise increase blood flow to the skin and can raise absorption. Wrapping a joint in an occlusive bandage does the same. If you plan to apply an ointment before a drug test or alongside medications, these are the circumstances that matter most.
Practical steps and thresholds
Read the label for base type. Ointments and salves with oil- and wax-rich bases will penetrate more than watery lotions. Note whether it is described as cosmetic or a drug delivery product; delivery claims change expectations. Check concentration. Product concentration and total applied dose both matter for the small amount that reaches blood. Do not apply to open wounds or freshly shaved skin unless the label supports it. Do not cover with a sealed wrap for systemic dosing unless a clinician advised that use. Keep a simple record if you use it alongside prescription drugs, given the low but nonzero absorption.
Warnings worth taking seriously: Stop if new rash, hives, or breathing difficulty appears; those are allergic signs, not expected effects. Do not rely on topical CBD to treat a systemic condition; any reach into blood is too small to be reliable. Be aware that unregulated products may list a content that does not match the batch tested by independent labs.
On the numerical side, treat labels cautiously. The absorption fraction for intact skin is very low, and no fixed conversion factor reliably maps ointment dose to blood concentration across products. The honest answer is that you cannot calculate a reliable blood level from a jar label alone.
What the evidence cannot settle
Consumer CBD ointments have far less absorption research behind them than oral forms or purified transdermal drug products. A 2017 review of CBD found that skin penetration studies mostly used designed transdermal formulations, not commercial cosmetic salves. Since then, standards remain inconsistent. There is no universal threshold for "meaningful" blood levels from a topical, because meaningful depends on the clinical goal.
The body of skin-absorption research also shows large person-to-person variation. The same ointment can produce different levels in different people and on different body sites. Skin thickness differs by site; forearm skin is different from a knee or the scalp. The takeaway is not that the product is unsafe, but that predictions are uncertain. Independent lab testing of specific products, batch by batch, is the most useful next step for any buyer who cares about what actually crosses the skin.
The final caveat involves the strongest absorption scenarios. When skin is damaged or occlusion is used, the absorbed fraction can climb well above typical intact-skin rates. That is a real edge case, not a theoretical one. Treat those conditions as a change in dose, not a minor variation.